SCHEMBL4827464

SCHEMBL4827464

CCOC(=O)c1cnn(-c2nc(-c3cccc([N+](=O)[O-])c3)cs2)c1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.61
KMT2A Q03164 5/20 0.61
MAPT P10636 10/20 0.60
ALDH1A1 P00352 7/20 0.60
KDM4E B2RXH2 5/20 0.60
HPGD P15428 5/20 0.60
L3MBTL1 Q9Y468 4/20 0.60
GAA P10253 2/20 0.60
CYP1A2 P05177 2/20 0.60
CYP2C9 P11712 2/20 0.60
CYP2C19 P33261 2/20 0.60
TDP1 Q9NUW8 1/20 0.57
LMNA P02545 2/20 0.51
RAB9A P51151 3/20 0.50
NPC1 O15118 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
MAPK1 P28482 1/20 0.49
ITGB2 P05107 1/20 0.48
ICAM1 P05362 1/20 0.48
ITGAL P20701 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12875507 0.88 MEN1 (0.75) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL12875535 0.87 KDM4E (0.66) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL12875579 0.86 KDM4E (0.65) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL12875511 0.85 KDM4E (0.64) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL1198997 0.83 KDM4E (0.71) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL1198929 0.82 KDM4E (0.68) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL12875515 0.80 KDM4E (0.59) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL12875584 0.80 KDM4E (0.59) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL7091428 0.79 MAPT (0.61) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL12875580 0.79 KDM4E (0.57) MEN1KMT2AMAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7358267-B2 Bis-aryl thiazole derivatives AMGEN INC. (US) 2008-04-15 US disclosed
US-7358267-B2 Bis-aryl thiazole derivatives AMGEN INC. (US) 2008-04-15 US disclosed
US-7358267-B2 Bis-aryl thiazole derivatives AMGEN INC. (US) 2008-04-15 US disclosed
US-20050215608-A1 Bis-aryl thiazole derivatives AMGEN INC. 2005-09-29 US disclosed
WO-2003002062-A2 BIS-ARYL THIAZOLE DERIVATIVES TULARIK INC. (US) 2003-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215608-A1 Bis-aryl thiazole derivatives FABP4, PC, TXNRD2 MEN1 4816/4885KMT2A 4093/4885MAPT 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.